Therapy for Heart Failure w/ Reduced Ejection Fraction - When & How to Introduce SGLT2 Inhibitors

Описание к видео Therapy for Heart Failure w/ Reduced Ejection Fraction - When & How to Introduce SGLT2 Inhibitors

A new class of agents with powerful effects on cardiovascular outcomes has quickly amassed a compelling body of evidence for its use: sodium-glucose cotransporter-2 (SGLT2) inhibitors.

Mayo Clinic https://mayocl.in/3tNMAdF
Follow Mayo Clinic on Instagram:   / mayoclinic  
Like Mayo Clinic on Facebook: https://www.facebook.com/
Follow Mayo Clinic on Twitter:   / mayoclinic  

Комментарии

Информация по комментариям в разработке